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ABSTRACT 
 
 
 
 
Ginger oil is well known for its potential as a bioactive phytochemical and 
long history of medicinal use with antioxidant, anti-obesity and cancer preventive 
activity.  Although many herbal drugs have potential to promote health in vitro 
findings they have shown less or no in vivo actions due to their poor solubility or 
improper molecular size or both, ultimately resulting in poor bioavailability and 
poor absorption which are the major limiting factors of development herbal drugs.  
Niosome as a lipid-based carrier system with remarkable advantages over 
conventional drug delivery systems was used as a carrier in this study in order to get 
the benefits of both herb and carrier.  Therefore, the main objective of this study was 
to formulate the ginger oil-loaded niosome.  Firstly, pre-formulation studies were 
carried out in order to investigate the feasibility of encapsulation ginger oil as a 
lipophilic active compound.  All niosome formulations were prepared by the film 
hydration method and characterized for drug entrapment efficiency (EE) and particle 
size (PS).  Niosome formulations were optimized with using Response Surface 
Methodology (RSM) based on Central Composite Design (CCRD).  Interaction of 
two formulation variables, namely amount of Span 60 (x1) and Labrasol (x2) which 
have great influence on particle size and entrapment efficiency were studied.  
Labrasol was determined as a key factor responsible for entrapment efficiency which 
increasing concentration of Labrasol from 0.45 (mM) to 2.5 (mM) has decreased 
around 10 % of entrapped drug.  In conclusion, the niosomes were successfully able 
to encapsulate ginger oil with high entrapment efficiency which can be useful in 
developing more effective use of ginger oil for human health.  
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ABSTRAK 
 
 
 
 
Minyak halia terkenal mempunyai potensi bioaktif fitokimia dan mempunyai 
sejarah penggunaan perubatan seperti antioksida, anti-obesiti, dan pencegahan 
aktiviti kanser. Melalui kaedah in vitro, pelbagai herba menunjukkan potensi 
memberansangkan dalam menggalakkan kesihatan, namun ia tidak dapat ditemui 
melalui kaedah in vivo yang disebabkan oleh kelarutan yang rendah atau kelemahan 
saiz molekul atau kedua-duanya sekali. Keadaan ini menyebabkan bioavailibiti dan 
penyerapan yang lemah seterusnya menjadi faktor penghalang utama dalam 
pembangunan ubatan herba. Niosome yang mempunyai kelebihan berbanding sistem 
penghantaran ubatan konvensional telah digunakan sebagai agen pembawa dalam 
kajian ini untuk mengekploitasi kelebihan bagi  herba dan pembawa . Oleh itu, 
objektif utama dalam kajian ini adalah untuk memformulakan niosome yang 
menyelaputi minyak halia. Kajian pra-formulasi dijalankan untuk menyelidik 
kebolehan penyalutan minyak halia sebagai komponen aktif yang bersifat lipophilik. 
Semua formula niosome telah disediakan dengan kaedah hidrasi filem dan 
dikategorikan untuk keberkesanan pemerangkapan herba  (EE) dan saiz partikel (PS). 
Formula niosome telah dioptimumkan dengan menggunakan Response Surface 
Methodology (RSM) berdasarkan Central Composite Design (CCRD). Interaksi 
antara dua formula pembolehubah iaitu jumlah Span 60 (X1) dan Labrasol (X2) 
yang mana mempengaruhi saiz partikel dan keberkesanan pemerangkapan telah 
dikaji. Labrasol ditemui sebagai faktor utama yang memberi kesan terhadap 
keberkesanan pemerangkapan yang mana peningkatan dalam kepekatan Labrasol 
daripada 0.45 (mM) kepada 2.5 (mM) akan mengurangkan herba yang terperangkap 
sebanyak 10 %. Kesimpulannya, niosome berjaya menyelaputi minyak halia dengan 
pemerangkapan herba yang tinggi yang mana hasil kajian ini  boleh digunakan 
dalam membangunkan pengunaan halia secara efektif dan berkesan untuk kesihatan.. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Introduction 
 
 
In recent years, drug development programs focus on the natural materials, 
including plant bioactive due to dissatisfaction of synthetic chemical drugs for 
treatment of chronic diseases (Kusum et al ., 2010).  Use of herbal medicines has 
been increased due to their therapeutic effects and fewer side effects as compared to 
the modern medicines (Goyal et al ., 2011).  Ginger and its identified bioactive 
compounds have a long history of medicinal use. It has been known to have a strong 
anti-inflammatory, antioxidant and cancer preventive activities while in other 
literatures anti-obesity activity of ginger has been studied (Mansour et al ., 2012).  
Therefore, ginger with various therapeutic values for human health has been 
investigated in recent years (Atashak et al ., 2011). 
 
 
Since many natural substances were discovered, substantial attention has been 
focused on the development of novel drug delivery system especially for bioactive 
compounds and herbal drugs in order to find scientific approach to deliver the 
components and overcoming problems associated with plant medicines.  Several 
bioactive compounds have poor solubility and insufficient bioavailability like ginger 
2 
oil, which are common problems of new herbal drug molecules. Molecular size is 
another major limiting factor for herbal drug molecules to pass the biological 
membrane to be absorbed systematically following oral or topical administration.  
 
 
Nowadays with the development in the technology, novel carrier systems 
opens different approach towards the development of herbal drug delivery systems 
since they offer remarkable advantages over conventional formulations of plant 
actives.  Using novel delivery systems in herbal formulations has been reported with 
advantages such as enhancement of solubility, protection from toxicity, enhancement 
of pharmacological activity, enhancement of stability, bioavailability, improved 
tissue macrophages distribution, sustained delivery, and protection from physical and 
chemical degradation (Goyal et al ., 2011; Kusum et al ., 2010).  Increasing the 
efficacy and reducing the side effects of herbal compounds and herbs is the basic 
idea behind incorporating novel method of drug delivery in herbal medicines (Kusum 
et al ., 2010).  Among different novel carriers, niosome exhibits some remarkable 
features that make this kind of delivery system preferable over other kind of delivery 
systems (Kumarn and Rajeshwarrao, 2011). 
 
 
Niosome used as a carrier in this study in order to encapsulate ginger oil to 
obtain higher efficacy, performance and bioavailability of bioactive compounds.  
 
 
 
 
1.2   Research Background 
 
 
Potential features of natural products including higher reliance and safety, 
producing better results of natural products over synthetic drugs or surgery, high 
costs and potentially hazardous side effects of chemical drugs, development of 
natural products is one the areas of focus during last few decades.  Furthermore, it 
has been demonstrated that the compounds derived from botanicals instead of 
3 
chemicals are more easily metabolized by the body (Kusum et al ., 2010). For 
reasons mentioned above, a variety of natural resources, including crude extracts and 
isolated compounds from plants as an excellent alternative strategy for developing 
future cost-effective and safe drugs have been widely investigated (Löbenberg and 
Amidon, 2000; Ajazuddin and Saraf, 2010). 
 
 
Over the past several years, novel drug delivery systems for plant actives and 
extracts were one of the areas of phyto-formulation research which presented 
remarkable advantages over conventional formulations of plant actives and extracts 
(Ajazuddin and Saraf, 2010).  Among various novel formulation including 
nanocapsules, liposomes, polymeric nanoparticles, phytosomes, transferosomes 
microsphere, nanoemulsionsand ethosomes has been reported using bioactive and 
plant extracts, niosomes are attracting major attention as lipid based, nano-sized and 
novel colloidal carrier system in past few years due to their potential features and 
advantages (Gangwar et al ., 2012; Ramadan, 2010). 
 
 
In almost all of the niosome formulations that have been studied so far, 
cholesterol was used as a principal component for lipid part while, Labrasol as a well 
-known lipid-based excipient used in different drug formulations and showed key 
features for oral, (trans)dermal and ocular drug delivery systems (Koga et al ., 2006); 
(Mura et al ., 2009).  As a result, Labrasol can be a good alternative for cholesterol in 
niosome formulation since it is lipid based excipient with remarkable features. 
 
 
 
 
1.3   Problem Statement 
 
 
Nowadays due to dissatisfaction with high costs and potentially hazardous 
side-effects of available chemical drugs on the market, development of natural 
products especially various plant bioactive is under investigation as an alternative 
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approach for developing future effective and safe drugs(Moro and Basile, 2000; 
Finer, 2002; Colon-Gonzalez et al ., 2012).  
 
 
Conventional drug delivery systems for plant bioactive have been reported 
with some limitations.  These drawbacks could be eliminated with using novel drug 
carrier systems such as niosomes which have been showed remarkable advantages 
for both herbal and chemical drugs (Ajazuddin and Saraf, 2010). 
 
 
In summary, dissatisfaction of available chemical drugs for treatment of 
chronic diseases and drawbacks of conventional drug delivery systems are two major 
problems in current scientific world.  Ginger oil was used as a model in 
encapsulation of a hydrophobic compound which has poor water solubility, poor 
absorption and bioavailability through skin permeation.  This study was carried out 
to find a scientific approach to encapsulate ginger oil in niosome for the first time in 
order to have better therapeutic effect from ginger oil. 
 
 
 
 
1.4   Hypothesis 
 
 
Ginger oil which has been reported with various pharmaceutical values can be 
encapsulated in niosomes, as lipid based, nano-sized and colloidal herbal drug carrier 
system to enhance the efficacy and performance of bioactive. In this study, for the 
first time, based on the successes and the advantages of niosomes, encapsulation of 
ginger oil in niosome was carried out.  Enhancement of bioavailability, stability, 
therapeutic values and some other features of niosome, as a novel formulation, can 
be achieved.  It is expected to use niosome for delivery of ginger oil either for oral or 
topical administration in future research, so using Labrasol may leads to achieve 
higher intestinal absorption and bioavailability or promote drug penetration and 
permeation respectively. 
5 
 
1.5  Objectives of the study 
 
 
The main objective of this study is to formulate and evaluate ginger oil-
loaded niosome which was prepared by lipid layer hydration method.  
 
 
 
 
1.6 Scopes of the study 
 
 
In order to achieve the objective, three major scopes will be involved in this 
study: 
 
 
1. Formulation of the ginger oil-loaded niosome. 
2. Determination of main effects and interactions of variables.   
3. Optimization of the formulation parameters that affect two dependent 
parameters, entrapment efficiency (EE %) and particle size (PS) of ginger oil-
loaded niosome using Respond Surface Methodology (RSM). 
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